SV Health Investors
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
37Deep-tech portfolio34 active
3Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Imbria Pharmaceuticals
19Co-investorsShare a portfolio company
Portfolio · 37 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Imbria Pharmaceuticals | Biotech | Active | Dec 16, 2025 | $140.2M |
| Therini Bio | Biotech | Active | Sep 8, 2025 | $29.0M |
| Montara Therapeutics | Biotech | Active | Mar 13, 2025 | $28.0M |
| Nanopath | Medtech | Active | Feb 6, 2025 | $15.3M |
| CarePredict | Medtech | Active | Sep 13, 2024 | $33.7M |
| Sudo Biosciences | Biotech | Active | Feb 15, 2024 | $62.9M |
| Violet Therapeutics | Biotech | Active | May 5, 2023 | $7.4M |
| Adimab | Biotech | Active | Apr 2, 2012 | $13.8M |
| AdvanCell | Biotech | Active | — | — |
| Alchemab | Biotech | Active | — | — |
| Amphista Therapeutics | Biotech | Active | — | — |
| Artios Pharma | Biotech | Active | — | — |
| Autifony Therapeutics | Biotech | Active | — | — |
| AviadoBio | Biotech | Active | — | — |
| CellCentric | Biotech | Active | — | — |
| Cerevance | Biotech | Active | — | — |
| Cumulus | Medtech | Active | — | — |
| Draig Therapeutics | Biotech | Active | — | — |
| Enara Bio | Biotech | Active | — | — |
| F2G | Biotech | Active | — | — |
| Leal Therapeutics | Biotech | Active | — | — |
| LoQus23 Therapeutics | Biotech | Active | — | — |
| Mestag Therapeutics | Biotech | Active | — | — |
| Nimbus Therapeutics | Biotech | Active | — | — |
| Nitrase Therapeutics | Biotech | Active | — | — |
| NRG Therapeutics | Biotech | Active | — | — |
| Prelenia | Biotech | Active | — | — |
| Pulmocide | Biotech | Active | — | — |
| Quell Therapeutics | Biotech | Active | — | — |
| Rondo Therapeutics | Biotech | Active | — | — |
| Sitryx Therapeutics | Biotech | Active | — | — |
| Transposon | Biotech | Active | — | — |
| Trex Bio | Biotech | Active | — | — |
| TRIMTECH | Biotech | Active | — | — |
| Xilio Therapeutics | Biotech | Public | Feb 26, 2021 | $145.2M |
| Bicycle Therapeutics | Biotech | Public | — | — |
| Sionna Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#10
Portfolio exits#69
Raises, 12 months#22
Co-investors#113
Co-investors
- RA CapitalVenture capital4 shared
- Atlas VentureVenture capital3 shared
- Access BiotechnologyVenture capital2 shared
- Canaan PartnersVenture capital2 shared
- Polaris PartnersVenture capital2 shared
- Sanofi VenturesVenture capital2 shared
- SR OneVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- AbingworthVenture capital1 shared
- Catalio Capital ManagementVenture capital1 shared
Sectors
- Biotech34
- Medtech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.